Sexually Transmitted Disease Program
Control the person-to-person spread of sexually transmitted diseases (STDs).
- During its 2010 Legislative Session, the Rhode Island General Assembly passed a law expressly permitting Expedited Partner Therapy. Under the new law, health care providers are permitted to write prescriptions or to provide medications for the sex partners of patients to be delivered by the patients themselves. Health care providers are not required to see or to examine the sex partners.
- The number of gonorrhea cases reported in Rhode Island decreased from 973 in 2003 to 291 in 2010, a decline of 70 percent. The number of reported gonorrhea cases has not been this low since 1962.
- Ninety-three percent of primary and secondary syphilis cases were treated within 14 days of specimen collection and ninety-eight percent within 30 days of specimen collection.
What We Do
Monitor Reportable Infectious Diseases
- Identify newly diagnosed cases
- Analyze trends in newly diagnosed cases
- Locate people who have been exposed to STDs
- Contact them and refer them to screening services
Control Disease Outbreaks
- Plan public health responses to outbreaks of STDs
- React swiftly to contain STD outbreaks by identifying those who may have been exposed, and referring them to screening services, with treatment for those who have become infected
Key Focus Area
Infertility Prevention Project
Rhode Island, in collaboration with the CDC and Office of Population Affairs of the Department of Health and Human Services (HHS), supports a national Infertility Prevention Project that funds chlamydia and gonorrhea screening and treatment services for low-income, sexually active women attending family planning clinics in Rhode Island. This program has shown that routine screening of women can reduce chlamydia prevalence and pelvic inflammatory disease (PID) incidence in women.
The key components of the regional infertility prevention programs are:
- Clinical (screening, treatment, partner management)
- Training and Education (of clinicians and laboratorians)
- Laboratory (tests, bulk purchasing, performance, turn-around-time, quality assurance)
- Surveillance (local, state, regional data collection, management, and analysis).